Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures

癫痫发作后血脑屏障完整性和癫痫发生的炎症控制

基本信息

  • 批准号:
    9914359
  • 负责人:
  • 金额:
    $ 42.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-15 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary Accumulating evidence in animal models highlights that inflammation ensuing in the brain during status epilepticus (SE) may play a determinant role in ongoing seizures and their long-term detrimental consequences, independent of an infection or auto-immune cause. Studies in a multitude of animal models demonstrate that SE causes a rapid and intense inflammatory cascade in the forebrain involving interactions among neurons, reactive astrocytes, activated microglia, vascular endothelial cells and, eventually, infiltrating neutrophils and monocytes from the blood. The pathophysiological interactions among the various inflammatory molecules, and the sequence of events leading to their induction, have not yet been dissected. The broad cytokine burst and gliosis following SE is blunted in mice that have genetic ablations of COX-2 restricted to those principal forebrain neurons in which COX-2 is normally induced by SE, pointing to a role for COX-2 pathways in SE-induced inflammation including breakdown of the blood-brain barrier (BBB), which is sufficient to produce epilepsy. Previous work showed that the EP2 receptor mediates much of the COX-2 effect. We hypothesize that SE-related morbidity is largely due to activation of microglial EP2 receptors, which modulates production of cytokines that degrade the BBB. Our specific aims are: 1. To test the hypothesis that activated microglia rather than inflammatory monocytes are responsible for EP2- regulated BBB breakdown after seizures; 2. To test the hypothesis that IL- -secreted mediator and Epac the major EP2 signaling pathway that degrades the integrity of the blood-brain barrier after SE; 3. To determine whether EP2 activation plays a dominant role in the development of epilepsy or its comorbidities after SE. To address these aims we employ in vitro culture models of the BBB and in vivo SE models with cell- specific conditional knockouts of EP2. Immunohistochemical, western blot, FACS, qRT-PCR, EEG and behavioral assays are performed.
项目总结

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Why Is It so Hard to Do Good Science?
为什么做好科学研究这么难?
  • DOI:
    10.1523/eneuro.0188-18.2018
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Dingledine,Ray
  • 通讯作者:
    Dingledine,Ray
Functional Analysis of Brain-Engrafted Monocytes After Microglia Ablation in Mouse Models.
小鼠模型中小胶质细胞消融后脑移植单核细胞的功能分析。
A New Approach for Epilepsy.
治疗癫痫的新方法。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAYMOND J DINGLEDINE其他文献

RAYMOND J DINGLEDINE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAYMOND J DINGLEDINE', 18)}}的其他基金

Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
针对癫痫发作后认知缺陷的 EP2 拮抗剂的优化
  • 批准号:
    10467539
  • 财政年份:
    2022
  • 资助金额:
    $ 42.22万
  • 项目类别:
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
针对癫痫发作后认知缺陷的 EP2 拮抗剂的优化
  • 批准号:
    10732636
  • 财政年份:
    2022
  • 资助金额:
    $ 42.22万
  • 项目类别:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
利用 EP2 受体生物学选择性地靶向癫痫相关的神经炎症
  • 批准号:
    10356163
  • 财政年份:
    2020
  • 资助金额:
    $ 42.22万
  • 项目类别:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
利用 EP2 受体生物学选择性地靶向癫痫相关的神经炎症
  • 批准号:
    10171930
  • 财政年份:
    2020
  • 资助金额:
    $ 42.22万
  • 项目类别:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
利用 EP2 受体生物学选择性地靶向癫痫相关的神经炎症
  • 批准号:
    10570244
  • 财政年份:
    2020
  • 资助金额:
    $ 42.22万
  • 项目类别:
Probing the Protective Role of EZH2 in Epilepsy
探讨 EZH2 在癫痫中的保护作用
  • 批准号:
    10617699
  • 财政年份:
    2019
  • 资助金额:
    $ 42.22万
  • 项目类别:
Probing the Protective Role of EZH2 in Epilepsy
探讨 EZH2 在癫痫中的保护作用
  • 批准号:
    10398140
  • 财政年份:
    2019
  • 资助金额:
    $ 42.22万
  • 项目类别:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
癫痫发作后血脑屏障完整性和癫痫发生的炎症控制
  • 批准号:
    9272954
  • 财政年份:
    2016
  • 资助金额:
    $ 42.22万
  • 项目类别:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
癫痫发作后血脑屏障完整性和癫痫发生的炎症控制
  • 批准号:
    9159612
  • 财政年份:
    2016
  • 资助金额:
    $ 42.22万
  • 项目类别:
Regulation of epileptogenesis by the transcriptional repressor, REST
转录抑制因子 REST 对癫痫发生的调节
  • 批准号:
    8325008
  • 财政年份:
    2011
  • 资助金额:
    $ 42.22万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 42.22万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了